Playing It Safe? Hahn's Biosimilar View

Stephen Hahn, President Trump’s nominee for commissioner of the FDA, at his Senate confirmation hearing today
US FDA Commissioner nominee Stephen Hahn awaits the start of his Senate confirmation hearing on 20 November, where he responded to questions about biosimilars, vaping and other issues. • Source: Derrick Gingery
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from Biosimilars & Generics